This work is licensed under a Creative Commons Attribution 4.0 International License.
Sequence 9 from Patent US 20120302729
General Information
DRACP ID DRACP01409
Peptide Name Sequence 9 from Patent US 20120302729
Sequence DLFGR
Sequence Length 5
UniProt ID A0A2L0P0K3 P51592 O95071 Q80TP3 Q62671 Q9VXG8 O60503 P51830 Q9DGG6 Q9I0F4 Q9VW60 P98999 Q7UDY6 A2A870 Q3ZBA0 Q80VP0 Q7Z6L1 Q5R5Y0 P10857 P28962 Q9HCM7 P40469 D5GI81 Q9DUT3 B2W0
PubChem CID Not available
Origin Synthetic construct
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Not available
Disulfide/Other Bond Not available
N-terminal Modification Not available
C-terminal Modification Not available
Other Modification None
Chiral L
Physicochemical Information
Formula C27H42N8O8
Absent amino acids ACEHIKMNPQSTVWY
Common amino acids DFGLR
Mass 67821
Pl 6.34
Basic residues 1
Acidic residues 1
Hydrophobic residues 2
Net charge 0
Boman Index -1480
Hydrophobicity -36
Aliphatic Index 78
Half Life
Mammalian: 1.2 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 1
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US 2012/0302729 A1
Patent Title Anticancer anti-mortalin peptide antibody.
Other Iinformation Granted Patent Family: 8s / 8ex; Family Jurisdictions: EP, US, WO, JP; Legal Status: Inactive; Application No: 201013514755; Filed:Dec 9, 2010; Published: Nov 29, 2012; Earliest Priority: Dec 10, 2009; Granted: Nov 19, 2013
Other Published ID EP2511371A1 EP2511371A4
This work is licensed under a Creative Commons Attribution 4.0 International License.